To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Description of the SAGhE … - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Contact form


Note! If you want an answer on a question you must specify your email address

Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.

Journal article
Authors Anthony J Swerdlow
Rosie Cooke
Kerstin Albertsson-Wikland
Birgit Borgström
Gary Butler
Stefano Cianfarani
Peter Clayton
Joël Coste
Annalisa Deodati
Emmanuel Ecosse
Ruth Gausche
Claudio Giacomozzi
Wieland Kiess
Anita C S Hokken-Koelega
Claudia E Kuehni
Fabienne Landier
Marc Maes
Primus-E Mullis
Roland Pfaffle
Lars Sävendahl
Grit Sommer
Muriel Thomas
Sally Tollerfield
Gladys R J Zandwijken
Jean-Claude Carel
Published in Hormone research in paediatrics
Volume 84
Issue 3
Pages 172-183
ISSN 1663-2826
Publication year 2015
Published at Institute of Neuroscience and Physiology, Department of Physiology
Pages 172-183
Language en
Subject categories Pediatrics


The long-term safety of growth hormone treatment is uncertain. Raised risks of death and certain cancers have been reported inconsistently, based on limited data or short-term follow-up by pharmaceutical companies.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?